President Donald Trump has nominated Dr. Heidi Overton, the deputy director of the White House Domestic Policy Council, to be the next commissioner of the Food and Drug Administration (FDA). If confirmed by the Senate, she will replace former commissioner Marty Makary, who resigned in May amid policy disputes with White House advisers.
Key Takeaways
President Donald Trump has nominated Dr. Heidi Overton to lead the Food and Drug Administration (FDA). She will replace former commissioner Marty Makary, who resigned amid policy disputes.
- President Trump nominates Dr. Heidi Overton for FDA commissioner
- Overton replaces Marty Makary, who resigned in May 2024
- Overton currently serves as deputy director of the White House Domestic Policy Council
- She holds medical and doctoral degrees from UNM and Johns Hopkins
- Nomination follows her role in shaping Trump's health policies
Source Claims Check
High Consensus| Claim | Status | Reason | |
|---|---|---|---|
| Overton's Nomination | Broad Agreement | Trump nominates Dr. Heidi Overton for FDA commissioner | |
| Makary's Resignation | Broad Agreement | Makary resigned as FDA commissioner in May 2024 | |
| Overton's Current Role | Broad Agreement | Overton is deputy director of the White House Domestic Policy Council | |
| Overton's Educational Background | Broad Agreement | MD from UNM, PhD from Johns Hopkins | |
| Trump's Praise For Overton | Broad Agreement | Trump calls Overton a 'rockstar' on Truth Social |
Overton holds a medical degree from the University of New Mexico School of Medicine and earned a doctorate in clinical investigation from Johns Hopkins Bloomberg School of Public Health. She is board-certified in public health and general preventive medicine and previously worked under Makary during his tenure at the hospital. Overton has been influential in shaping significant health policies within the Trump administration, including overhauling childhood vaccine schedules and altering dietary guidelines.
Trump praised Overton on Truth Social, describing her as a 'rockstar' who has tackled some of the hardest issues, bringing solutions that work best for the country. The nomination follows Overton's role in shaping significant health policies within the Trump administration, including overhauling childhood vaccine schedules and altering dietary guidelines.
Overton's appointment is seen as part of Trump's push to implement his 'America First' policies at the FDA, which has lost more than 3,000 staff over the past year. She previously worked at the America First Policy Institute, a conservative think tank. The nomination has sparked mixed reactions from various stakeholders. Republican Sen. Bill Cassidy of Louisiana expressed concerns about Overton's lack of managerial experience and her role in the controversial vaccine executive order.
How this summary was created
This summary synthesizes reporting from 14 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.
